{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:27:17Z","timestamp":1794673637091,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recessive congenital methemoglobinemia (RCM) is a rare autosomal recessive disorder characterized by a deficiency of NADH-cytochrome b5 reductase. Under normal conditions, cytochrome b5 reductase and NADH reductase maintain methemoglobin in the physiological range by keeping heme iron in the Fe\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sup>+<\/jats:sup>\n                      state. RCM presents in two clinical forms. Type I presents with isolated cyanosis, while type II presents also with severe neurocognitive manifestations. Genetic analysis of the\n                      <jats:italic>CYB5R3<\/jats:italic>\n                      gene is often used for diagnosis. Treatment with methylene blue, ascorbic acid, or riboflavin can reduce cyanosis, but does not affect neurological outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>We conducted a systematic review of RCM, identifying all previously reported cases, including one from our center. In addition, we conducted a meta-analysis of individual participant data and provided a comprehensive review of clinical manifestations, genotype-phenotype correlations and treatment options, as well as proposing a diagnostic flow chart.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the case of RCM, diagnosis is primarily achieved through genetic analysis based on direct sequencing. The described pathogenic variants are specific to either type I or type II RCM when considered in combination with their allelic variants in compound heterozygous cases. Well known variants such as c.757G&gt;A is associated with type I in both homo- and heterozygous state. Whereas c.226G&gt; is associated with type I in compound heterozygous state with c.173G&gt;A or c.827C&gt;T and type 2 in homozygous state. Similar results are observed for multiple other variants. Ascorbic acid is the most commonly used treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04215-7","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:06:20Z","timestamp":1770192380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recessive congenital methemoglobinemia: a systematic review of reported cases"],"prefix":"10.1186","volume":"21","author":[{"given":"Julie","family":"Neven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessi","family":"Beyltjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije","family":"Meuwissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"De Bisschop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Bouziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2828-6226","authenticated-orcid":false,"given":"Machiel","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"6","key":"4215_CR1","first-page":"1218","volume":"72","author":"S Kanwal","year":"2022","unstructured":"Kanwal S, Aamir M, Irum S, Haroon Z, Munir MU, Bibi A. A case of congenital methaemoglobinaemia with secondary polycythemia. J Pak Med Assoc. 2022;72(6):1218\u201321.","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"4215_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2141.2008.07017.x","volume":"141","author":"MJ Percy","year":"2008","unstructured":"Percy MJ, Lappin TR. Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency. Br J Haematol. 2008;141(3):298\u2013308.","journal-title":"Br J Haematol"},{"issue":"12","key":"4215_CR3","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/ajh.26340","volume":"96","author":"A Iolascon","year":"2021","unstructured":"Iolascon A, Bianchi P, Andolfo I, Russo R, Barcellini W, Fermo E, et al. Recommendations for diagnosis and treatment of methemoglobinemia. Am J Hematol. 2021;96(12):1666\u201378.","journal-title":"Am J Hematol"},{"issue":"1","key":"4215_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40748-022-00142-0","volume":"8","author":"ANJ Lyle","year":"2022","unstructured":"Lyle ANJ, Spurr R, Kirkey D, Albert CM, Billimoria Z, Perez J, et al. Case report of congenital methemoglobinemia: an uncommon cause of neonatal cyanosis. Matern Health Neonatol Perinatol. 2022;8(1):7.","journal-title":"Matern Health Neonatol Perinatol"},{"key":"4215_CR5","doi-asserted-by":"crossref","unstructured":"Guedri R, Missaoui N, Essaddam L, Ben Becher S. A rare cause of cyanosis: Congenital methemoglobinemia. Clin Case Rep 2021. 9(7):e04422.","DOI":"10.1002\/ccr3.4422"},{"issue":"1","key":"4215_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0005-2728(72)90024-2","volume":"275","author":"PG Passon","year":"1972","unstructured":"Passon PG, Hultquist DE. Soluble cytochrome b 5 reductase from human erythrocytes. Biochim Biophys Acta. 1972;275(1):62\u201373.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4215_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/0006-291X(87)91122-3","volume":"148","author":"M Takeshita","year":"1987","unstructured":"Takeshita M, Tamura M, Kugi M, Matsuki T, Yoneyama Y, Igarashi T. Decrease of palmitoyl-CoA elongation in platelets and leukocytes in the patient of hereditary methemoglobinemia associated with mental retardation. Biochem Biophys Res Commun. 1987;148(1):384\u201391.","journal-title":"Biochem Biophys Res Commun"},{"key":"4215_CR8","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular pathology. Genet Med. 2015;17(5);405\u2013424.","DOI":"10.1038\/gim.2015.30"},{"issue":"2","key":"4215_CR9","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1542\/peds.112.2.e158","volume":"112","author":"SS Da-Silva","year":"2003","unstructured":"Da-Silva SS, Sajan IS, Underwood JP. 3rd. Congenital methemoglobinemia: a rare cause of cyanosis in the newborn-a case report. Pediatrics. 2003;112(2):e158\u201361.","journal-title":"Pediatrics"},{"key":"4215_CR10","first-page":"11","volume":"6","author":"C Tasci","year":"2012","unstructured":"Tasci C, Nevruz O, Candir N, Bilgic H. A methemoglobinemia case who was previously diagnosed and treated as asthma. Respir Med Case Rep. 2012;6:11\u201312.","journal-title":"Respir Med Case Rep"},{"issue":"3","key":"4215_CR11","first-page":"e35974","volume":"15","author":"M Aldeeb","year":"2023","unstructured":"Aldeeb M, Khalil IA, Yassin MA. Congenital methemoglobinemia in a 33-year-old patient: a case report on a rare presentation and a review of the literature. Cureus. 2023;15(3):e35974.","journal-title":"Cureus"},{"issue":"3","key":"4215_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/MPH.0000000000000489","volume":"38","author":"A Alonso-Ojembarrena","year":"2016","unstructured":"Alonso-Ojembarrena A, Lubian-Lopez SP. Hemoglobin M disease as a cause of cyanosis in a newborn. J Pediatr Hematol Oncol. 2016;38(3):173\u201375.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"4215_CR13","first-page":"e16081","volume":"13","author":"M Alsabri","year":"2021","unstructured":"Alsabri M, Viswanathan K, Elias A, Peichev M. Congenital methemoglobinemia and unstable hemoglobin variant in a Child with cyanosis. Cureus. 2021;13(7):e16081.","journal-title":"Cureus"},{"key":"4215_CR14","doi-asserted-by":"publisher","first-page":"Pt, 3: 760","DOI":"10.1093\/brain\/awm337","volume":"131","author":"C Ewenczyk","year":"2008","unstructured":"Ewenczyk C, Leroux A, Roubergue A, Laugel V, Afenjar A, Saudubray JM, et al. Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum. Brain. 2008;131:Pt, 3: 760\u20131.","journal-title":"Brain"},{"issue":"4","key":"4215_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/humu.31","volume":"17","author":"W Kugler","year":"2001","unstructured":"Kugler W, Pekrun A, Laspe P, Erdlenbruch B, Lakomek M. Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) gene. Hum Mutat. 2001;17(4):348.","journal-title":"Hum Mutat"},{"issue":"1","key":"4215_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1090-3798(02)00135-6","volume":"7","author":"E Fazzi","year":"2003","unstructured":"Fazzi E, Signorini SG, Scelsa B, Bova SM, Lanzi G. Leber\u2019s congenital amaurosis: an update. Eur J Paediatr Neurol. 2003;7(1):13\u201322.","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"4215_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/humu.23973","volume":"41","author":"V Gupta","year":"2020","unstructured":"Gupta V, Kulkarni A, Warang P, Devendra R, Chiddarwar A, Kedar P. Mutation update: variants of the CYB5R3 gene in recessive congenital methemoglobinemia. Hum Mutat. 2020;41(4):737\u201348.","journal-title":"Hum Mutat"},{"key":"4215_CR18","doi-asserted-by":"crossref","unstructured":"Yang Y, Yang Y, Meng Y, Huang L, Yang Z. Novel compound heterogeneous mutations in CYB5R3 gene leading to methemoglobinemia (type I) in a Chinese boy: case report and relevant comprehensive analysis. Acta Haematol. 2024;1\u20137.","DOI":"10.1159\/000539448"},{"key":"4215_CR19","first-page":"44","volume":"5","author":"P Warang","year":"2015","unstructured":"Warang P, Kedar P, Sivanandam S, Jothilakshmi K, Sumathi R, Colah R. A novel nine base deletion mutation in NADH-cytochrome b5 reductase gene in an Indian family with recessive congenital methemoglobinemia-type-II. Mol Genet Metab Rep. 2015;5:44\u201347.","journal-title":"Mol Genet Metab Rep"},{"key":"4215_CR20","unstructured":"Mayo clinic laboratories, cytochrome b5 reductase enzyme activity. Blood 2023, https:\/\/www.mayocliniclabs.com\/test-catalog\/overview\/65609#Clinical-and-Interpretive."},{"key":"4215_CR21","doi-asserted-by":"crossref","unstructured":"Iolascon A, Andolfo I, Russo R, Barcellini W, Fermo E, Toldi G, et al. Summary of joint European Hematology Association (EHA) and EuroBloodNet recommendations on diagnosis and treatment of methemoglobinemia. Hemasphere 2021. 5(12):e660.","DOI":"10.1097\/HS9.0000000000000660"},{"issue":"3","key":"4215_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1210\/jc.2008-1745","volume":"95","author":"RC Kok","year":"2010","unstructured":"Kok RC, Timmerman MA, Wolffenbuttel KP, Drop SL, de Jong FH. Isolated 17, 20-lyase deficiency due to the cytochrome b5 mutation W27X. J Clin Endocrinol Metab. 2010;95(3):994\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl, 1","key":"4215_CR23","first-page":"93","volume":"61","author":"I Ivek","year":"2022","unstructured":"Ivek I, Knotek T, Ivicic T, Rubinic B, Bajlo P, Hamzic J. Methemoglobinemia - a case report and literature review. Acta Clin Croat. 2022;61(Suppl, 1):93\u201398.","journal-title":"Acta Clin Croat"},{"issue":"3","key":"4215_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/tme.12666","volume":"30","author":"P Singh","year":"2020","unstructured":"Singh P, Rakesh K, Agarwal R, Tripathi PP, Dhooria S, Sehgal IS, et al. Therapeutic whole blood exchange in the management of methaemoglobinemia: case series and systematic review of literature. Transfus Med. 2020;30(3):231\u201339.","journal-title":"Transfus Med"},{"issue":"5","key":"4215_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.12809\/hkmj209028","volume":"27","author":"TT Chan","year":"2021","unstructured":"Chan TT, Leung WCY, Chan CK, Lo HKT, Tso WWY, Tsui SH, et al. Clinical experience in diagnosis and management of acquired methaemoglobinaemia: a case report and retrospective review. Hong Kong Med J. 2021;27(5):366\u201369.","journal-title":"Hong Kong Med J"},{"key":"4215_CR26","doi-asserted-by":"crossref","unstructured":"Barakizou H, Chaieb S. Familial psychomotor delay of an uncommon cause: type II congenital methemoglobinemia. Clin Med Insights Pediatr. 2024;18.","DOI":"10.1177\/11795565241229007"},{"key":"4215_CR27","doi-asserted-by":"publisher","unstructured":"Nayak AR, et al. Unmasking congenital methemoglobinemia: novel CYB5R mutation discovered in an adult with symptomatic polycythemia. Turk J Hematol. 2024;281\u201382. https:\/\/doi.org\/10.4274\/tjh.galenos.2024.2024.0232.","DOI":"10.4274\/tjh.galenos.2024.2024.0232"},{"key":"4215_CR28","doi-asserted-by":"publisher","first-page":"119930","DOI":"10.1016\/j.cca.2024.119930","volume":"564","author":"K He","year":"2025","unstructured":"He K, et al. Clinica Chimica Acta a novel stoploss mutation CYB5R3 c. 906A > G (p.* 302Trpext * 42) involved in the pathogenesis of hereditary methemoglobinemia. Clin Chim Acta. 2025;564:119930.","journal-title":"Clin Chim Acta"},{"key":"4215_CR29","first-page":"1","volume":"59","author":"A Ullah","year":"2023","unstructured":"Ullah A, et al. Molecular dynamic simulation analysis of a novel missense variant in CYB5R3 gene in patients with methemoglobinemia. Med. 2023;59:1\u201313.","journal-title":"Med"},{"key":"4215_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/JBM.S395865","volume":"14","author":"A Al-Abdulmalek","year":"2023","unstructured":"Al-Abdulmalek A, Al-Sulaiman R, Abu-Tineh M, Yassin MA. Congenital methemoglobinemia: first confirmed case in the Arab population with a novel variant in the CYB5R gene in the state of Qatar: a case report. J Blood Med. 2023;14:247\u201351.","journal-title":"J Blood Med"},{"key":"4215_CR31","doi-asserted-by":"crossref","unstructured":"Nakata M, et al. Hereditary congenital methemoglobinemia diagnosed at the age of 79 years: a case report. Med. 2023;59.","DOI":"10.3390\/medicina59030615"},{"key":"4215_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clinbiochem.2022.01.008","volume":"102","author":"D Molina Herranz","year":"2022","unstructured":"Molina Herranz D, et al. CYB5R3 homozygous pathogenic variant as a rare cause of cyanosis in the newborn. Clin Biochem. 2022;102:67\u201370.","journal-title":"Clin Biochem"},{"key":"4215_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijpam.2020.01.003","volume":"8","author":"HS AlFaris","year":"2021","unstructured":"AlFaris HS, Elhissi G, Chedrawi A, Al-Muhaizea MA. Beyond a routine blood gas, an easily picked but missed diagnosis of chronic encephalopathy. Int J Pediatr Adolesc Med. 2021;8:52\u201354.","journal-title":"Int J Pediatr Adolesc Med"},{"key":"4215_CR34","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s11033-021-07031-3","volume":"49","author":"A Deorukhkar","year":"2022","unstructured":"Deorukhkar A, Kulkarni A, Kedar P. Three novel mutations in CYB5R3 gene causing NADH-cytochrome b5 reductase enzyme deficiency leads to recessive congenital methaemoglobinemia. Mol Biol Rep. 2022;49:2141\u201347.","journal-title":"Mol Biol Rep"},{"key":"4215_CR35","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00277-020-04141-z","volume":"100","author":"J Ji","year":"2021","unstructured":"Ji J, Liu Y, Chen M. Type I congenital methemoglobinemia in a Chinese family. Ann Hematol. 2021;100:2417\u201319.","journal-title":"Ann Hematol"},{"key":"4215_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr-2020-236677","volume":"13","author":"L Izadi Firouzabadi","year":"2020","unstructured":"Izadi Firouzabadi L, Mead P. Congenital methaemoglobinaemia presenting in a 55-year-old man. BMJ Case Rep. 2020;13:1\u20132.","journal-title":"BMJ Case Rep"},{"key":"4215_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1542\/peds.2018-2814","volume":"143","author":"J Ward","year":"2019","unstructured":"Ward J, et al. Congenital methemoglobinemia identified by pulse oximetry screening. Pediatrics. 2019;143:5\u20137.","journal-title":"Pediatrics"},{"key":"4215_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1971400918822153","volume":"32","author":"M Nicolas-Jilwan","year":"2019","unstructured":"Nicolas-Jilwan M. Recessive congenital methemoglobinemia type II: hypoplastic basal ganglia in two siblings with a novel mutation of the cytochrome b5 reductase gene. Neuroradiol J. 2019;32:143\u201347.","journal-title":"Neuroradiol J"},{"key":"4215_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/10245332.2018.1444920","volume":"23","author":"PS Kedar","year":"2018","unstructured":"Kedar PS, Gupta V, Warang P, Chiddarwar A, Madkaikar M. Novel mutation (R192C) in CYB5R3 gene causing NADH-cytochrome b5 reductase deficiency in eight Indian patients associated with autosomal recessive congenital methemoglobinemia type-I. Hematology. 2018;23:567\u201373.","journal-title":"Hematology"},{"key":"4215_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ams2.335","volume":"5","author":"F Yamaji","year":"2018","unstructured":"Yamaji F, et al. A new mutation of congenital methemoglobinemia exacerbated after methylene blue treatment. Acute Med Surg. 2018;5:199\u2013201.","journal-title":"Acute Med Surg"},{"key":"4215_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ccr3.1310","volume":"6","author":"EA Mannino","year":"2018","unstructured":"Mannino EA, et al. Congenital methemoglobinemia type II in a 5-year-old boy. Clin Case Rep. 2018;6:170\u201378.","journal-title":"Clin Case Rep"},{"key":"4215_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4081\/hr.2018.7221","volume":"10","author":"DS Soliman","year":"2018","unstructured":"Soliman DS, Yassin M. Congenital methemoglobinemia misdiagnosed as polycythemia vera: case report and review of literature. Hematol Rep. 2018;10:7\u201310.","journal-title":"Hematol Rep"},{"key":"4215_CR43","first-page":"194","volume":"76","author":"KF de Geus","year":"2018","unstructured":"de Geus KF, et al. Congenital methaemoglobinaemia in a 61-year-old patient with normal haemoglobin levels. Neth J Med. 2018;76:194\u201397.","journal-title":"Neth J Med"},{"key":"4215_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MPH.0000000000000705","volume":"39","author":"TE Burtseva","year":"2017","unstructured":"Burtseva TE, Ammosova TN, Protopopova NN, Yakovleva SY, Slobodchikova MP. Enzymopenic congenital methemoglobinemia in children of the republic of Sakha (Yakutia). J Pediatr Hematol Oncol. 2017;39:42\u201345.","journal-title":"J Pediatr Hematol Oncol"},{"key":"4215_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.24953\/turkjped.2016.01.019","volume":"58","author":"D Aslan","year":"2016","unstructured":"Aslan D, T\u00fcrk\u00f6z-Sucak G, Percy MJ. Recessive congenital methemoglobinemia in immediate generations. Turk. J. Pediatr. 2016;58:113\u201315.","journal-title":"Turk. J. Pediatr"},{"key":"4215_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13760-015-0502-4","volume":"116","author":"AA Ozcelik","year":"2016","unstructured":"Ozcelik AA, Perk P, Dai A. Congenital methemoglobinemia type 2 and cerebellar atrophy\/hypoplasia. Acta Neurol Belg. 2016;116:217\u201319.","journal-title":"Acta Neurol Belg"},{"key":"4215_CR47","first-page":"44","volume":"5","author":"P Warang","year":"2015","unstructured":"Warang P, et al. A novel nine base deletion mutation in NADH-cytochrome b5 reductase gene in an Indian family with recessive congenital methemoglobinemia-type-II. Mol Genet Metab Rep. 2015;5:44\u201347.","journal-title":"Mol Genet Metab Rep"},{"key":"4215_CR48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3109\/03630269.2015.1065882","volume":"39","author":"A Forestier","year":"2015","unstructured":"Forestier A, et al. Congenital recessive methemoglobinemia revealed in adulthood: description of a new mutation in cytochrome b5 reductase gene. Hemoglobin. 2015;39:438\u201341.","journal-title":"Hemoglobin"},{"key":"4215_CR49","doi-asserted-by":"publisher","first-page":"NP139","DOI":"10.1177\/0883073813512026","volume":"29","author":"K Devadathan","year":"2014","unstructured":"Devadathan K, Sreedharan M, Sarasam S, Colah RB, Kunju PAM. Neurometabolic disorder with microcephaly, dystonia, and central cyanosis masquerading as cerebral palsy. J Child Neurol. 2014;29:NP139\u201342.","journal-title":"J Child Neurol"},{"key":"4215_CR50","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.jvca.2012.12.010","volume":"28","author":"B Champigneulle","year":"2014","unstructured":"Champigneulle B, et al. Late diagnosis of congenital methemoglobinemia in an elderly patient during cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28:730\u201332.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"4215_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cca.2014.07.015","volume":"437","author":"P Kedar","year":"2014","unstructured":"Kedar P, et al. Primaquine-induced severe methemoglobinemia developed during treatment of Plasmodium vivax malarial infection in an Indian family associated with a novel mutation (p.Agr57Trp) in the CYB5R3 gene. Clin Chim Acta. 2014;437:103\u201305.","journal-title":"Clin Chim Acta"},{"key":"4215_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000347041","volume":"130","author":"K Rawa","year":"2013","unstructured":"Rawa K, et al. Characterization of a novel mutation in the NADH-cytochrome b5 reductase gene responsible for rare hereditary methaemoglobinaemia type i. Acta Haematol. 2013;130:122\u201325.","journal-title":"Acta Haematol"},{"key":"4215_CR53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bcmd.2012.05.005","volume":"49","author":"YH Huang","year":"2012","unstructured":"Huang YH, et al. Recessive congenital methemoglobinemia caused by a rare mechanism: maternal uniparental heterodisomy with segmental isodisomy of a chromosome 22. Blood Cells, Mol Dis. 2012;49:114\u201317.","journal-title":"Blood Cells, Mol Dis"},{"key":"4215_CR54","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00277-012-1513-3","volume":"91","author":"P Kedar","year":"2012","unstructured":"Kedar P, Warang P, Ghosh K, Colah R. Recessive congenital methemoglobinemia due to NADH-cytochrome b5 reductase deficiency associated with recurrent early pregnancy loss (REPL) in an Indian family. Ann Hematol. 2012;91:1985\u201386.","journal-title":"Ann Hematol"},{"key":"4215_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/MPH.0b013e318257a492","volume":"34","author":"MJ Percy","year":"2012","unstructured":"Percy MJ, et al. Methemoglobin reductase deficiency: novel mutation is associated with a disease phenotype of intermediate severity. J Pediatr Hematol Oncol. 2012;34:457\u201360.","journal-title":"J Pediatr Hematol Oncol"},{"key":"4215_CR56","unstructured":"Cooper MS, et al. Congenital methemoglobinemia type II-Clinical improvement with short-term methylene blue treatment. Pediatr Blood Cancer 1388-1389. 2016."},{"key":"4215_CR57","doi-asserted-by":"crossref","unstructured":"V1 FRL, Phillips1 JD, N R. Molecular basis of two novel mutations found in type I methemoglobinemia. Blood Cells Mol Dis. 2011;277\u201381.","DOI":"10.1016\/j.bcmd.2011.01.005"},{"key":"4215_CR58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ajh.21956","volume":"86","author":"PS Kedar","year":"2011","unstructured":"Kedar PS, Warang P, Ghosh K, C RB. Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: compound heterozygous for NADH-cytochrome b5 reductase gene mutations. Am J Hematol. 2011;86:325\u201327.","journal-title":"Am J Hematol"},{"key":"4215_CR59","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/08880010902979233","volume":"26","author":"T Arkoglu","year":"2009","unstructured":"Arkoglu T, et al. A novel L218p mutation in nadh-cytochrome b5 reductase associated with type i recessive congenital methemoglobinemia. Pediatr Hematol Oncol. 2009;26:381\u201385.","journal-title":"Pediatr Hematol Oncol"},{"key":"4215_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bcmd.2007.09.006","volume":"40","author":"PS Kedar","year":"2008","unstructured":"Kedar PS, Warang P, Nadkarni AH, Colah RB, Ghosh K. A novel G143D mutation in the NADH-cytochrome b5 reductase gene in an Indian patient with type I recessive hereditary methemoglobinemia. Blood Cells, Mol Dis. 2008;40:323\u201327.","journal-title":"Blood Cells, Mol Dis"},{"key":"4215_CR61","first-page":"76","volume":"35","author":"YS Hamirani","year":"2008","unstructured":"Hamirani YS, Franklin W, Grifka RG, Stainback RF. Methemoglobinemia in a young man. Tex Hear Inst J. 2008;35:76\u201377.","journal-title":"Tex Hear Inst J"},{"key":"4215_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bcmd.2008.02.002","volume":"41","author":"E Fermo","year":"2008","unstructured":"Fermo E, et al. Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene. Blood Cells, Mol Dis. 2008;41:50\u201355.","journal-title":"Blood Cells, Mol Dis"},{"key":"4215_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.abb.2005.12.015","volume":"447","author":"MJ Percy","year":"2006","unstructured":"Percy MJ, Crowley LJ, Boudreaux J, Barber MJ. Expression of a novel P275L variant of NADH: cytochrome b5 reductase gives functional insight into the conserved motif important for pyridine nucleotide binding. Arch Biochem Biophys. 2006;447:59\u201367.","journal-title":"Arch Biochem Biophys"},{"key":"4215_CR64","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1600-0609.2004.00388.x","volume":"74","author":"A Leroux","year":"2005","unstructured":"Leroux A, Leturcq F, Deburgrave N, Szajnert MF. Prenatal diagnosis of recessive congenital methaemoglobinaemia type II: novel mutation in the NADH-cytochrome b5 reductase gene leading to stop codon read-through. Eur J Haematol. 2005;74:389\u201395.","journal-title":"Eur J Haematol"},{"key":"4215_CR65","first-page":"A, 101","volume":"133","author":"\u00d6 \u00c7ogulu","year":"2005","unstructured":"\u00c7ogulu \u00d6, Yilmaz D, Ozkinay F, Kavakli K, Roos D. A novel mutation in the DIA1 gene in a patient with methemoglobinemia type II [2]. Am J Med Genet. 2005;133:A, 101\u2013102.","journal-title":"Am J Med Genet"},{"key":"4215_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.thj.6200380","volume":"5","author":"MJ Percy","year":"2004","unstructured":"Percy MJ, Oren H, Savage G, Irken G. Congenital methaemoglobinaemia type I in a Turkish infant due to novel mutation, Pro144Ser, in NADH-cytochrome b5 reductase. Hematol J. 2004;5:367\u201370.","journal-title":"Hematol J"},{"key":"4215_CR67","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00431-004-1409-x","volume":"163","author":"SP Toelle","year":"2004","unstructured":"Toelle SP, Boltshauser E, M\u00f6ssner E, Zurbriggen K, Eber S. Severe neurological impairment in hereditary methaemoglobinaemia type 2. Eur J Pediatr. 2004;163:207\u201309.","journal-title":"Eur J Pediatr"},{"key":"4215_CR68","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1034\/j.1600-0609.2003.00070.x","volume":"70","author":"D Grabowska","year":"2003","unstructured":"Grabowska D, et al. Compound heterozygosity of two missense mutations in the NADH-cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemia. Eur J Haematol. 2003;70:404\u201309.","journal-title":"Eur J Haematol"},{"key":"4215_CR69","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/blood-2002-05-1405","volume":"100","author":"MJ Percy","year":"2002","unstructured":"Percy MJ, et al. Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase. Blood. 2002;100:3447\u201349.","journal-title":"Blood"},{"key":"4215_CR70","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1182\/blood.V97.4.1106","volume":"97","author":"J Dekker","year":"2001","unstructured":"Dekker J, et al. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b5 reductase gene leading to methemoglobinemia type I. Blood. 2001;97:1106\u201314.","journal-title":"Blood"},{"key":"4215_CR71","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1182\/blood.V95.10.3250","volume":"95","author":"Y Wang","year":"2000","unstructured":"Wang Y, et al. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia. Blood. 2000;95:3250\u201355.","journal-title":"Blood"},{"key":"4215_CR72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/1098-1004(200007)16:1<18::AID-HUMU4>3.0.CO;2-N","volume":"16","author":"CM Aalfs","year":"2000","unstructured":"Aalfs CM, Salieb-Beugelaar GB, Wanders RJA, Mannens MMAM, Wijburg FA. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis. Hum Mutat. 2000;16:18\u201322.","journal-title":"Hum Mutat"},{"key":"4215_CR73","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1046\/j.1365-2141.1998.01123.x","volume":"103","author":"K Higasa","year":"1998","unstructured":"Higasa K, et al. Molecular basis of hereditary methaemoglobinaemia, types I and II: two novel mutations in the NADH-cytochrome b5 reductase gene. Br J Haematol. 1998;103:922\u201330.","journal-title":"Br J Haematol"},{"key":"4215_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0009-8981(98)00022-9","volume":"273","author":"FH Lan","year":"1998","unstructured":"Lan FH, Tang YC, Huang CH, Wu YS, Zhu ZY. Antibody-based spot test for NADH-cytochrome b5 reductase activity for the laboratory diagnosis of congenital methemoglobinemia. Clin Chim Acta. 1998;273:13\u201320.","journal-title":"Clin Chim Acta"},{"key":"4215_CR75","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1023\/A:1005379730729","volume":"20","author":"EP Owen","year":"1997","unstructured":"Owen EP, Berens J, Marinaki AM, I H, H EH. Recessive congenital methaemoglobinaemia type II, a new mutation which causes incorrect splicing in the NADH-cytochrome b5 reductase gene. J Inher Metab Dis. 1997;20:610.","journal-title":"J Inher Metab Dis"},{"key":"4215_CR76","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood.V87.7.2993.bloodjournal8772993","volume":"87","author":"MM Jenkins","year":"1996","unstructured":"Jenkins MM, Prchal JT. A novel mutation found in the 3\u2032 domain of NADH-cytochrome B5 reductase in an African-American family with type I congenital methemoglobinemia. Blood. 1996;87:2993\u201399.","journal-title":"Blood"},{"key":"4215_CR77","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1182\/blood.V88.8.3208.bloodjournal8883208","volume":"88","author":"JI Manabe","year":"1996","unstructured":"Manabe JI, et al. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia. Blood. 1996;88:3208\u201315.","journal-title":"Blood"},{"key":"4215_CR78","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1182\/blood.V85.8.2254.bloodjournal8582254","volume":"85","author":"LM Vieira","year":"1995","unstructured":"Vieira LM, Kaplan JC, Kahn A, Leroux A. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. Blood. 1995;85:2254\u201362.","journal-title":"Blood"},{"key":"4215_CR79","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1016\/S0021-9258(17)37554-3","volume":"269","author":"K Shirabe","year":"1994","unstructured":"Shirabe K, Fujimoto Y, Yubisui T, Takeshita M. An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme. J Biol Chem. 1994;269:5952\u201357.","journal-title":"J Biol Chem"},{"key":"4215_CR80","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/BF00202825","volume":"93","author":"SJ Giordano","year":"1994","unstructured":"Giordano SJ, Kaftory A, Steggles AW. A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism. Hum Genet. 1994;93:568\u201370.","journal-title":"Hum Genet"},{"key":"4215_CR81","doi-asserted-by":"publisher","first-page":"20416","DOI":"10.1016\/S0021-9258(19)88718-5","volume":"267","author":"K Shirabe","year":"1992","unstructured":"Shirabe K, et al. Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type). J Biol Chem. 1992;267:20416\u201321.","journal-title":"J Biol Chem"},{"key":"4215_CR82","first-page":"799","volume":"48","author":"T Katsube","year":"1991","unstructured":"Katsube T, et al. Exonic point mutations in NADH-cytochrome b5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency. Am J Hum Genet. 1991;48:799\u2013808.","journal-title":"Am J Hum Genet"},{"key":"4215_CR83","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood.V75.7.1408.1408","volume":"75","author":"Y Kobayashi","year":"1990","unstructured":"Kobayashi Y, Fukumaki Y, Yubisui T, Inoue J, Sakaki Y. Serine-proline replacement at residue 127 of NADH-cytochrome b5 reductase causes hereditary methemoglobinemia, generalized type. Blood. 1990;75:1408\u201313.","journal-title":"Blood"},{"key":"4215_CR84","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/0002-9343(90)90384-P","volume":"89","author":"JT Prchal","year":"1990","unstructured":"Prchal JT, et al. Congenital methemoglobinemia due to methemoglobin reductase deficiency in two unrelated American black families. Am J Med. 1990;89:516\u201322.","journal-title":"Am J Med"},{"key":"4215_CR85","first-page":"285","volume":"64","author":"A Das Gupta","year":"1980","unstructured":"Das Gupta A, et al. Associated red cell enzyme deficiencies and their significance in a case of congenital enzymopenic methemoglobinemia. Acta Haematol. 1980;64:285\u201388.","journal-title":"Acta Haematol"},{"key":"4215_CR86","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/BF02535839","volume":"15","author":"H Hirono","year":"1980","unstructured":"Hirono H. Lipids of myelin, white matter and gray matter in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation. Lipids. 1980;15:272\u201375.","journal-title":"Lipids"}],"updated-by":[{"DOI":"10.1186\/s13023-026-04372-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04215-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04215-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04215-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:04:18Z","timestamp":1781651058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04215-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4215"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04215-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13023-026-04372-9","URL":"https:\/\/doi.org\/10.1186\/s13023-026-04372-9","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the index patient included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"89"}}